End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-02-09FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution manufactured by Vantive US Hea…
-
FDA approval · 2015-02-09FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution containing sodium chloride, sodium la…
-
FDA approval · 2015-01-08FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
The FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose, electrolytes, and lactate, manufactured by…
-
FDA approval · 2014-12-09FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Extraneal (icodextrin-containing peritoneal dialysis solution) submitted by Vantive US Healt…
-
FDA approval · 2014-12-08FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution manufactured by Fresenius Medical Care North America.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-06FDA Approved: CALCIUM ACETATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves Amneal Pharmaceuticals of New York LLC's calcium acetate under an Original Application (ANDA) as a generic phosphate binder to …
-
FDA approval · 2014-09-30FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution. It is manufactured by Vantive…
-
FDA approval · 2014-09-30FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
The FDA approved a supplemental application for Dianeal Low Calcium with Dextrose, a peritoneal dialysis solution from Vantive US Healthcare…
-
FDA approval · 2014-09-30FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for DIANEAL PD-2 WITH DEXTROSE, a peritoneal dialysis solution, manufactured by Vantive US Healthcar…
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved Fosrenol (lanthanum carbonate) through Takeda's original NDA to treat hyperphosphatemia in adults with chronic kidney disea…
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-09-24FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) from Fresenius Medical Care Renal Therapies Group, LLC.
-
FDA approval · 2014-08-07FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care North America, comprising dextrose …
-
FDA approval · 2014-04-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dextrose-based dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V.,…
-
FDA approval · 2014-04-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysis solution consisting of dextrose and electrolytes, produced by Fresenius Medi…
-
FDA approval · 2014-04-23FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysate solution from Fresenius Medical Care de Mexico, S.A. de C.V., updating the …
-
FDA approval · 2014-04-23FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX dialysis solution from Fresenius Medical Care North America.
-
FDA approval · 2014-02-04FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Extraneal, a peritoneal dialysis solution containing icodextrin and electrolytes, submitted by V…
-
FDA approval · 2014-01-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose and electrolytes, manufactured by Fresenius Med…
-
FDA approval · 2014-01-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysate solution, submitted by Fresenius Medical Care North America.
-
FDA approval · 2014-01-13FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental NDA for DELFLEX from Fresenius Medical Care North America. This action represents an update to the product's…
-
FDA approval · 2013-08-15FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care North America. It is formulated wit…
-
FDA approval · 2013-04-26FDA Approved: EXTRANEAL — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for Extraneal (icodextrin) submitted by Vantive US Healthcare LLC.
-
FDA approval · 2013-04-26FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approved a supplemental application for DIANEAL LOW CALCIUM WITH DEXTROSE, a peritoneal dialysis solution from Vantive US Healthcare LLC…
-
FDA approval · 2013-04-26FDA Approved: DIANEAL LOW CALCIUM WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)
FDA approves a supplemental application for Dianeal Low Calcium with Dextrose, adding a low-calcium peritoneal dialysis solution variant to …